XML 59 R41.htm IDEA: XBRL DOCUMENT v3.25.1
Income Taxes (Tables)
12 Months Ended
Mar. 31, 2025
Income Tax Disclosure [Abstract]  
Schedule of Income (Loss) From Continuing Operations Before Income Taxes
Years Ended March 31,
(In millions)202520242023
Income from continuing operations before income taxes
U.S.$3,735 $2,597 $3,308 
Foreign624 1,192 1,322 
Income from continuing operations before income taxes$4,359 $3,789 $4,630 
Schedule of Income Tax Expense (Benefit) Related to Continuing Operations
Income tax expense related to continuing operations consists of the following:
Years Ended March 31,
(In millions, except percentages)202520242023
Current
Federal$552 $867 $619 
State182 231 126 
Foreign254 134 180 
Total current988 1,232 925 
Deferred
Federal102 (360)(46)
State(133)36 
Foreign(217)(110)(10)
Total deferred(110)(603)(20)
Income tax expense $878 $629 $905 
Reported income tax rate20.1 %16.6 %19.5 %
Schedule of Reconciliation Between Effective Tax Rate on Income From Continuing Operations and Statutory Tax Rate
The reconciliation of income tax expense and the amount computed by applying the statutory federal income tax rate of 21.0% to income before income taxes was as follows:
Years Ended March 31,
(In millions)202520242023
Income tax expense at federal statutory rate$915 $796 $972 
State income taxes, net of federal tax benefit145 104 134 
Tax effect of foreign operations(25)(16)(85)
Foreign-derived intangible income(83)(67)(60)
Unrecognized tax benefits and settlements91 116 
Net tax benefit on intellectual property repatriation and sales
(258)(104)— 
Canadian disposal transaction loss140 — — 
Valuation allowance release— (157)— 
Share-based compensation(42)(37)(58)
Other, net(5)(6)(4)
Income tax expense$878 $629 $905 
Schedule of Deferred Tax Balances
Deferred tax balances consisted of the following:
March 31,
(In millions)20252024
Assets
Receivable allowances$136 $244 
Opioid-related litigation and claims680 680 
Compensation and benefit-related accruals287 277 
Net operating loss and credit carryforwards847 751 
Lease obligations423 438 
Capitalized research and development cost68 60 
Intangibles66 
Other170 147 
Subtotal2,677 2,602 
Less: valuation allowance(644)(653)
Total assets2,033 1,949 
Liabilities
Inventory valuation and other assets(2,139)(2,092)
Fixed assets (72)(16)
Lease right-of-use assets(434)(431)
Other(50)(10)
Total liabilities(2,695)(2,549)
Net deferred tax liability$(662)$(600)
Long-term deferred tax asset$367 $317 
Long-term deferred tax liability(1,029)(917)
Net deferred tax liability$(662)$(600)
Schedule of Gross Unrecognized Tax Benefits
The following table summarizes the activity related to the Company’s gross unrecognized tax benefits for the last three fiscal years:
Years Ended March 31,
(In millions)202520242023
Unrecognized tax benefits at beginning of period$1,463 $1,399 $1,523 
Additions based on tax positions related to prior years33 10 — 
Reductions based on tax positions related to prior years(43)(2)(26)
Additions based on tax positions related to current year97 64 21 
Reductions based on settlements(13)(8)(96)
Reductions based on the lapse of the applicable statutes of limitations(7)(2)(16)
Exchange rate fluctuations(7)
Unrecognized tax benefits at end of period$1,532 $1,463 $1,399